Meet the Other Phone. Child-safe in minutes.

Meet the Other Phone.
Child-safe in minutes.

Buy now

Please or to access all these features

Covid

Mumsnet doesn't verify the qualifications of users. If you have medical concerns, please consult a healthcare professional.

People who fall ill with Covid while double-vaccinated may get ‘super-immunity’, researchers say Antibodies following a ‘breakthrough’ infection can be 1,000 per cent stronger than vaccination alone,

6 replies

Beadebaser · 21/12/2021 19:12

From the Independent today.

OP posts:
jgw1 · 21/12/2021 19:16

@Beadebaser

From the Independent today.
So we shoudn't be having the booster?
Beadebaser · 21/12/2021 19:20

@jgw1 the study wouldn’t have been able to cover that yet I guess - maybe that would give you super duper immunity!

OP posts:
actiongirl1978 · 21/12/2021 19:21

I bloody hope so. I've had 3 jabs and covid twice. I should be immune for a while now surely!

Waxonwaxoff0 · 21/12/2021 19:21

Hmm. I caught Covid after one vaccination, then got my second when I recovered. I've not booked my booster yet.

jgw1 · 21/12/2021 19:22

[quote Beadebaser]@jgw1 the study wouldn’t have been able to cover that yet I guess - maybe that would give you super duper immunity![/quote]
Well I think we should probably hold of boosters until we know.

UnmentionedElephantDildo · 21/12/2021 19:27

Original paper here

jamanetwork.com/journals/jama/fullarticle/2787447?guestAccessKey=b13a6814-c63d-4fa0-b2ae-a4511de8aedb&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121621

Concluding discussion paragraph

Results of this study showed substantial boosting of humoral immunity after breakthrough infection, despite predominantly mild disease. Boosting was most notable for IgA, possibly due to the differences in route of exposure between vaccination and natural infection. In addition, breakthrough sera demonstrated improved variant cross-neutralization, and Delta breakthrough infections in particular exhibited improved potency against Delta vs WA1, suggesting that the protective immune response may be broadened through development of variant boosters with antigenic inserts matching the emerging SARS-CoV-2 variants. Limitations of this study include the small number of samples and the difference in time from initial vaccination to serum collection between the breakthrough and control groups, which emerging evidence suggests may contribute to the development of variant cross-neutralizing antibody responses

New posts on this thread. Refresh page